A B S T R A C T In Bin deficiency, inadequate DNA synthesis seems due in large measure to a block of tetrahydrofolic acid (THFA) regeneration from 5-methyl THFA (via homocysteine transmethylation).
INTRODUCTION
Defective de novo DNA synthesis, as measured by reduced incorporation of deoxyuridine (dU) into the thymine of DNA, has been found in bone marrow from patients with B,2-or folate-deficient megaloblastic anemia (1, 2) . It was demonstrated (2) that this defect was partially corrected by added Bu in the Bi2-deficient but not the folate-deficient marrows and completely corrected by pteroylglutamic acid (PGA) in both types of deficient marrows. The corrective effect of Bn was blocked by methotrexate (MTX) (a folate antagonist). 5-methyltetrahydrofolic acid (THFA), which may accumulate in Bu deficiency (3, 4) , failed to correct the defect in DNA synthesis in Bin-deficient marrows (2) , unless Bu was added to the culture system.' The conversion of 5-methyl THFA to THFA via homocysteine transmethylation is dependent on a Bn enzyme (5) (6) (7) . These findings support the concept that inadequate DNA synthesis in B1 deficiency is due in large measure to reduced 5-methyl folate utilization brought about by lack of Bn (Fig. 1) .
In the present study, the effect of homocysteine (substrate) and methionine (product) on the homocysteine transmethylation step was studied (8) . Addition of homocysteine would be expected to release accumulated 5-methyl THFA and increase the THFA available for de novo thymidylate (dTMP) synthesis. Conversely, methionine would be expected to decrease available THFA.
METHODS
Effective de novo synthesis of dTMP from dU in human bone marrow was measured by the ability of 1 hr preincubation with dU to suppress incorporation into DNA of subsequently added thymidine-3H (TdR-8H) as previously described by Killman (1) In this system abnormal de novo DNA synthesis in megaloblastic anemia was demonstrable by reduced ability of preincubation (at room temperature for 1 hr) with dU to suppress incorporation of subsequently added TdR-'H (1 juc/ tube). For culture, 15-20 ml of marrow was aspirated into a syringe containing 10 ml of cold Hank's solution with heparin (10,000 U). All operations were carried out as previously described by Metz et al. (2) . The radioactive precursor used was methyl thymidine-2H (specific activity 12.5 c/mmole/liter), prepared as a solution containing 10 Ac/ml with a concentration during the incubation experiments of 0.134 mgtmole/ml. After 3 hr incubation at 370C, RNA and DNA were extracted from the lysate by the technic described by Feinendegen, Bond, and Painter (9) as modified by Cooper and Rubin (10) . The radioactivity of the RNA and DNA extracts was measured in a Picker liquid scintillation counter (Picker Nuclear, New York), and results were expressed as total radioactivity incorporated into DNA. At the time of aspiration of the bone marrow samples, venous blood was assayed for serum B1, (11) and folate (12) .
Patients studied. 11 patients with megaloblastic bone marrow changes were studied. Five patients (Nos. 1-5) had B1, deficiency, 3 patients (Nos. 6-8) had nutritional folate deficiency, and 3 patients (Nos. 9-11) had MTX-induced folate deficiency. The serum vitamin levels, degree of megaloblastic change in the marrow, and dU suppression effect are shown in Table I . Control subjects (patient Nos. 12-16) were TdR, thymidine. In our laboratory, serum vitamin B12 levels below 100 pg/ml and folate levels below 3 ng/ml indicate unequivocal deficiency. The lower limit for unequivocally normal serum vitamin B12 level is 200 pg/ml and for folate, 7 ng/ml. Serum folate above 24 ng/ml is above our upper limit of normal. * Degree of megaloblastosis.
Studied on several occasions (Fig. 6 ).
nonanemic hospital patients with normoblastic marrows and normal serum Bu, and folate levels. RESULTS Effect of homocysteine and methionine on dU suppression of TdR-'H incorporation into DNA in normal marrow. In normal marrow the dU enters the deoxyuridylate (dUMP)-dTMP-thymine of DNA pathway, so that the incorporation of TdR-8H is diminished. The degree of diminution (suppression) of TdR-8H uptake is thus a measure of dUMP incorporated into DNA. In normal marrow, TdR-3H uptake was diminished to 10% or less of control values (i.e., samples preincubated without added dU) when the marrow was preincubated with dU 10' umole/tube (Fig. 2) , as previously reported (2). This diminution (suppression) implies normal DNA synthesis. The addition of L-homocysteine (1 mg/tube) with dU had little effect on the normal dUsuppressive effect on TdR-3H uptake into DNA. L-Methionine (1 mg/tube) reduced the dU effect (P <0.01), most dramatically in patients 13 and 16 who were alcoholics with low-normal serum folate level. PGA (50 ,ug/tube), when added with methionine and dU, returned the dU effect to normal range.
Effect of homocysteine and methionine on dU sup- correction (P < 0.02) (Fig. 3) (Fig. 6) . Before MTX therapy, dU suppressed TdR-8H. incorporation into DNA in normal fashion. Marrows, although morphologically normoblastic 12 hr after the patient received 5 mg and then 20 mg of MTX, demonstrated nevertheless inability of dU to suppress TdR-3H into DNA. This effect was greater after the larger dose of MTX. When added in vitro, methionine enhanced MTX effect in direct relationship to the amount of MTX taken by the patient. Homocysteine, when added in vitro, appeared to correct the defective dU effect produced by in vivo MTX. DISCUSSION dTMP for DNA synthesis (13) can arise either via the salvage pathway, from preformed TdR (14) , or via the de novo pathway, from dUMP ( Fig. 1) (15) . In the de novo sequence, the one-carbon unit is reduced and transferred from 5,10-methylene THFA to dUMP. This process is accompanied by the oxidation of THFA to dihydrofolic acid (DHFA) (16) . Thus, in order for de novo dTMP synthesis to proceed, THFA must be continuously available and acquire a one-carbon unit to become 5,10-methylene THFA. THFA availability may be reduced by nutritional folate deficiency, folic acid antagonists, or by interference with the homocysteinemethionine transmethylation pathway (which depends on a B= enzyme), whose main function in man may be to regenerate THFA from 5-methyl THFA. In vitro evidence previously reported (2) suggests that subnormal synthesis of the thymine of DNA in B12-deficient megaloblastic bone marrow is due in significant measure to deranged folate metabolism associated with the B12 deficiency. Herbert and Zalusky (3) showed that L. casei-active material, subsequently identified as 5-methyl THFA (4) In the system utilized in the current studies, reduced de novo DNA synthesis in megaloblastic bone marrow appeared to be due to interference with the methylation of dUMP to dTMP, which is unequivocally a folate-dependent step (17) (18) (19) (20) (21) (22) (23) (24) . Homocysteine enhanced B11 correction of the defective de novo dTMP synthesis in B12-deficient marrow, perhaps by releasing stores of 5-methyl THFA for regeneration of THFA. Correction by homocysteine of the reduced dU suppression of TdR-3H in either the absence of Bn or in the presence of Big anilide (a B12 antagonist) in Bn-deficient marrow may support the possibility in man of an additional, Bis-independent pathway for regeneration of THFA by methylation of homocysteine to form methionine, as has been suggested by the preliminary studies of Foster in man (25) (27) in chickens and Kutzback, Galloway, and Stokstad (28) in rats. The methionine effect in the present study appeared to be related to the availability of THFA, because the most marked effect in normal marrows occurred in two alcoholic patients with low-normal folate levels, and the methionine effect could be corrected by the addition of PGA.
Methionine has been reported to aggravate clinical Budeficient megaloblastic anemia (29) and also to decrease formiminoglutamic acid urinary excretion (30) (31) (32) . Katzen (33) has demonstrated that the synthesis of 5,10-methylene THFA reductase is severely repressed by methionine in bacteria, but Kutzback et al. (28) found no such repression in rat liver by methionine. Methionine appears to have a regulatory role via the transmethylation reaction in the tissue distribution of folic acid coenzymes. The importance in man of homocysteine transmethylation may be to regenerate THFA rather than to generate methionine, since methionine is abundantly available in the diet.
The effect of varying amounts of MTX in vitro and in vivo was measured by the dU suppression of TdR-'H uptake into DNA. Reduced dU suppression of TdR-8H was exaggerated as a patient received more MTX and was apparent before any morphologic evidence of megaloblastosis was evident. In vitro studies revealed that MTX effect could be enhanced by methionine, perhaps by blocking THFA regeneration from 5-methyl THFA. Such an effect would be additive to the MTX ability to block THFA production from PGA and DHFA by binding dihydrofolate reductase (34) (35) (36) (37) . Homocysteine appeared to correct MTX effect in vitro, perhaps by releasing intracellular stores of 5-methyl THFA for THFA regeneration, thus by-passing the blocked DHFA. The efficacy of methionine to potentiate and homocysteine to reduce MTX action in vivo is now under study.
